Svetlana Lucas

Director, aTyr Pharma.

Companies

Scribe Therapeutics, Inc.Chief Business Officer Jul 23, 2026 to now¹
Jasper Therapeutics, Inc.Board member Jun 20, 2024 to now²
aTyr PharmaBoard member Jul 2, 2019 to now³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Scribe Therapeutics, Inc. SCTX33,695 shares⁴$661.3K at $19.62Jul 23, 2026
Jasper Therapeutics, Inc. JSPR20,000 shares⁵$9.5K at $0.48Sep 22, 2025
aTyr Pharma ATYR6,000 shares⁶$1.0K at $0.17Apr 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 23, 2026Bought 3,000 shares at $15.00 of Scribe Therapeutics, Inc.⁷
Sep 22, 2025Bought 20,000 shares at $2.43 of Jasper Therapeutics, Inc.⁵
Apr 26, 2023Exercised options 6,000 shares of aTyr Pharma⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARScribe Therapeutics, Inc., Chief Business Officer
2
SEC EDGARJasper Therapeutics, Inc., Board member
3
SEC EDGARaTyr Pharma, Board member
4
SEC EDGARScribe Therapeutics, Inc. shares after the filing of Jul 23, 2026
5
SEC EDGARJasper Therapeutics, Inc. shares after the filing of Sep 22, 2025
6
SEC EDGARaTyr Pharma shares after the filing of Apr 26, 2023
7
SEC EDGARForm 4 filed Jul 27, 2026